Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia

Leuk Lymphoma. 2020 Oct;61(10):2497-2501. doi: 10.1080/10428194.2020.1765236. Epub 2020 May 18.

Authors

Charles Gaulin¹, Angela Chan², Andriy Derkach³, Jae H Park², Simon Mantha⁴, Mark B Geyer², Martin S Tallman²

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Division of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 32420774
DOI: 10.1080/10428194.2020.1765236

No abstract available

Publication types

Letter

MeSH terms

Afibrinogenemia* / complications
Afibrinogenemia* / diagnosis
Disseminated Intravascular Coagulation* / diagnosis
Disseminated Intravascular Coagulation* / etiology
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy